- Motley Fool•18 hours ago
Big pharma is reeling from President-elect Trump's press-conference comments that the industry is "getting away with murder."
- Motley Fool•2 days ago
Intercept Pharmaceuticals' presentation at the J.P. Morgan Healthcare Conference could give a sneak peek at the future for Gilead Sciences.
- Motley Fool•3 days ago
Pharma and biotech companies have been put on notice, but so has Donald Trump.
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||73.00 - 73.78|
|52 Week Range||70.83 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.76|
|Dividend & Yield||1.88 (2.57%)|
|1y Target Est||N/A|